“…Several alternative cryptococcosis invertebrate models have been introduced including Caenorhabditis elegans ( Mylonakis et al., 2002 ; Mylonakis et al., 2004 ), Drosophila melanogaster ( Apidianakis et al., 2004 ), and Galleria mellonella ( Mylonakis et al., 2005 ). In a previous study, our laboratory showed that both C. neoformans ATCC#32045 and C. gattii ATCC#56992 can reduce the lifespan of C. elegans by regulating the insulin/insulin-like growth factor-1 (IGF-1) signaling (IIS) pathway and DAF-16 has been shown to play a central role during cryptococcal infections ( Kitisin et al., 2022 ). Although C. elegans has been extensively used as a model to screen targeted drugs for anti-Parkinson effects ( Chalorak et al., 2018 ; Malaiwong et al., 2019 ), however, the study of C. elegans neurodegeneration caused by pathogenic fungal infections has been limited.…”